Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 213

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 6
Chunk 213
---
, directors or service providers of those companies and the percentage of that equity that has been issued or granted as of March 17, 2025 (in both cases, after including shares underlying options).

Subsidiary    Percentage of Subsidiary's Equity Issuable as Equity Incentives         Percentage of Equity Granted as of March 17, 2025     
                                                                                                     as Equity Incentives                   
--------------------------------------------------------------------------------------------------------------------------------------------
AgPlenus                                                                  13.8   %                                                   8.9   %
Biomica                                                                     12   %                                                  7.62   %
Casterra                                                                   7.5   %                                                   3.9   %
Lavie Bio                                                                 10.5   %                                                   8.8   %
 
Grants under our subsidiaries’ equity incentive plans may qualify for favorable treatment under the tax law provisions of the United States or Israel.
 
 The share-based payments under our subsidiary equity incentive plans are presented as non-controlling interests in the financial statements and were valued at approximately $1.4 million in 2024, as detailed in Note 17g to the financial statements included in this Annual Report under Item 18.

C.          Board Practices
 
Board of Directors
 
Under the Companies Law and our articles of association, the supervision of the management of our business is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to executive management. Our Chief Executive Officer (referred to as a “general manager” under the Companies Law) is responsible for our day-to-day management. Our Chief Executive Officer is appointed by, and serves at the discretion of, our board of directors, subject to the employment agreement that we have entered into with him. All other executive officers are appointed by the Chief Executive Officer and are subject to the terms of any applicable employment agreements that we may enter into with them.
 
Under our articles of association and the Companies Law, our board of directors must consist of not less than three and no more than seven directors. Currently our board of directors consists of six directors.
 
Our directors are elected annually, by a simple majority vote of holders of our voting shares participating and voting at the annual meeting of our shareholders, for a one-year term, from the annual general meeting of our shareholders at which they are elected until the next annual general meeting and until their respective successors are elected and qualified or until their earlier removal by our shareholders at a general meeting, or upon the occurrence of certain events